companydata.dkBIODANE PHARMA A/S: Financial statements 2015
CVR: 28310102
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 437,995 and a net result of DKK -253,036 compared with DKK -250,379 the year before. That is an increase of 57% compared with the year before. Equity amounted to DKK 733,542. The solvency ratio was 87.4%.
- Gross Profit
- 437,995 kr.
- Profit/Loss
- -253,036 kr.
- Equity
- 733,542 kr.
- Total Assets
- 839,257 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 438 t. | -253 t. | 734 t. | - |
| 2014 | - | 279 t. | -250 t. | 987 t. | - |
| 2013 | - | 106 t. | -977 t. | -263 t. | - |
| 2012 | - | 384 t. | 8 t. | 714 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
BIODANE PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 278,919, and the net result was DKK -250,379.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.